CN110404038A - Pharmaceutical composition for Shenque Moxa - Google Patents
Pharmaceutical composition for Shenque Moxa Download PDFInfo
- Publication number
- CN110404038A CN110404038A CN201910578046.4A CN201910578046A CN110404038A CN 110404038 A CN110404038 A CN 110404038A CN 201910578046 A CN201910578046 A CN 201910578046A CN 110404038 A CN110404038 A CN 110404038A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- shenque
- moxa
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/06—Devices for heating or cooling such points within cell-life limits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rehabilitation Therapy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
This application discloses a kind of pharmaceutical composition for Shenque Moxa, the bulk pharmaceutical chemicals including following parts by weight: 10-30 parts of fennel seeds；10-30 parts of cortex cinnamomi；10-30 parts of ramulus cinnamomi；10-30 parts of Caulis Spatholobi；10-30 parts of Radix Angelicae Sinensis；10-30 parts of tuber fleeceflower stem；10-30 parts of olibanum of part；10-30 parts of myrrh；10-30 parts of rhizoma zingiberis；2-6 parts of muscone.The pharmaceutical composition of the application has the effect of warming spleen and stomach for dispelling cold, qi-restoratives, clearing and activating the channels and collaterals, analgesic, activating microcirculation and removing stasis medicinal.
Description
Technical field
This application involves a kind of pharmaceutical compositions, more particularly to a kind of pharmaceutical composition for Shenque Moxa.
Background technique
Shenque Moxa exactly directly applies drug on SHENQUE acupoint, then is treated with moxa-moxibustion in patient's umbilical region, excite channels and collaterals it
Gas, the promoting flow of qi and blood, conditioning viscera, to prevent and treat a kind of external therapy of disease.Shenque moxibustion is a kind of benign to human body
Stimulation, it is of great advantage to building up health, no matter sick body, being healthy and strong and can use, especially to the weakness of the spleen and the stomach caused chronic gastropathy
There is good effect, there is preferable abdomen gasification function, to menalgia, pelvic hydrops and senile prostatitis, increasing
The tools such as frequent micturition, urgent urination caused by the raw, failure of the kidney in receiving air have a better effect.
Existing navel treatment technology is single, can not comprehensively achieve the effect that conditioning or treatment.In the prior art not yet
One kind can include Shenque administration respectively, and ginger is treated, the complex treatment Opsonizing method that moxa-moxibustion is integrated.
Summary of the invention
Aiming to overcome that the above problem or at least being partially solved or extenuate for the application solves the above problems.
According to the one aspect of the application, a kind of pharmaceutical composition for Shenque Moxa, including following weight are provided
The bulk pharmaceutical chemicals of part:
A kind of pharmaceutical composition for Shenque Moxa, the bulk pharmaceutical chemicals including following parts by weight:
10-30 parts of fennel seeds；10-30 parts of cortex cinnamomi；10-30 parts of ramulus cinnamomi；10-30 parts of Caulis Spatholobi；10-30 parts of Radix Angelicae Sinensis；Night hands over
10-30 parts of rattan；10-30 parts of olibanum of part；10-30 parts of myrrh；10-30 parts of rhizoma zingiberis；2-6 parts of muscone.
Optionally, the pharmaceutical composition for Shenque Moxa, the bulk pharmaceutical chemicals including following parts by weight:
15-25 parts of fennel seeds；15-25 parts of cortex cinnamomi；15-25 parts of ramulus cinnamomi；15-25 parts of Caulis Spatholobi；15-25 parts of Radix Angelicae Sinensis；Night hands over
15-25 parts of rattan；15-25 parts of olibanum of part；15-25 parts of myrrh；15-25 parts of rhizoma zingiberis；3-5 parts of muscone.
Optionally, the pharmaceutical composition for Shenque Moxa, the bulk pharmaceutical chemicals including following parts by weight:
20 parts of fennel seeds；20 parts of cortex cinnamomi；20 parts of ramulus cinnamomi；20 parts of Caulis Spatholobi；20 parts of Radix Angelicae Sinensis；20 parts of tuber fleeceflower stem；20 parts of olibanum；
20 parts of myrrh；20 parts of rhizoma zingiberis；4 parts of muscone.
The present invention is used for the effect of pharmaceutical composition of Shenque Moxa:
Fennel seeds: have effects that warming kidney for dispelling cold, cold-dispelling pain-relieving, regulating qi-flowing for harmonizing stomach.
Cortex cinnamomi: have effects that sedation and analgesia, cooling, antibacterial, promoting menstruation.
The effect of ramulus cinnamomi: having sweating expelling pathogenic factors from muscles and skin, and Wen Jing activates yang.
Caulis Spatholobi: have effects that blood pressure lowering, hematopoiesis of enriching blood, anticancer.
Radix Angelicae Sinensis: have effects that relax bowel and defecation, activating microcirculation and removing stasis medicinal, menstruction regulating and pain relieving.
Tuber fleeceflower stem: have effects that nourishing blood and tranquilization, dispelling wind and removing obstruction in the meridians, antiphlogistic antibacterial, reducing blood lipid.
Olibanum: have effects that anti-inflammatory anti-corrosion, inducing meastruation to relieve menalgia, detumescence and promoting granulation.
Myrrh: have effects that promoting blood circulation and stopping pain, detumescence and promoting granulation, dissipate blood and dissolving stasis.
Rhizoma zingiberis: have effects that promoting blood circulation and stopping pain, detumescence and promoting granulation, dissipate blood and dissolving stasis.
Muscone: effect of resuscitation with aromatics, degrading the channel, swelling and pain relieving etc..
The application belongs to topical administration, and medication, ginger are treated the complex treatment Opsonizing method being combined as a whole with moxa-moxibustion, had
Simplicity is tested honest and clean, reaches warming spleen and stomach for dispelling cold, has a qi-restoratives, clearing and activating the channels and collaterals, analgesic, and activating microcirculation and removing stasis medicinal increases the effect of body immunity.
The present invention enumerates Shenque administration respectively, and ginger is treated, and the complex treatment Opsonizing method that moxa-moxibustion is integrated is tested with simplicity
It is honest and clean, meet theory of traditional Chinese medical science.
Specific embodiment
The application is described further below by specific embodiment:
Embodiment 1
Raw material (gram) is weighed according to following weight:
20 grams of fennel seeds；20 grams of cortex cinnamomi；20 grams of ramulus cinnamomi；20 grams of Caulis Spatholobi；20 grams of Radix Angelicae Sinensis；20 grams of tuber fleeceflower stem；20 grams of olibanum；
20 grams of myrrh；20 grams of rhizoma zingiberis；4 grams of muscone.
Preparation method: spare at medicinal powder by the above raw material mixed grinding to 300 mesh.
Application method: cleaning SHENQUE acupoint is included in 2 grams above-mentioned of navel moxibustion medicinal powder, 50 grams of ginger powder are tuned into pie with warm water, put
On Shenque, medicinal powder is covered.It puts 7 grams of 20:1 moxa above to light, moxibustion three is strong or one is strong, once a day.Pay attention to keeping warm, is within 5 days
One course for the treatment of.
Embodiment 2
Raw material (gram) is weighed according to following weight:
10 grams of fennel seeds；30 grams of cortex cinnamomi；10 grams of ramulus cinnamomi；30 grams of Caulis Spatholobi；10 grams of Radix Angelicae Sinensis；30 grams of tuber fleeceflower stem；10 grams of olibanum；
30 grams of myrrh；10 grams of rhizoma zingiberis；2 grams of muscone.
Preparation method: spare at medicinal powder by the above raw material mixed grinding to 400 mesh.
Application method: cleaning SHENQUE acupoint is included in 2 grams above-mentioned of navel moxibustion medicinal powder, 50 grams of ginger powder are tuned into pie with warm water, put
On Shenque, medicinal powder is covered.It puts 7 grams of 20:1 moxa above to light, moxibustion three is strong or one is strong, once a day.Pay attention to keeping warm, is within 5 days
One course for the treatment of.
Embodiment 3
Raw material (gram) is weighed according to following weight:
30 grams of fennel seeds；10 grams of cortex cinnamomi；30 grams of ramulus cinnamomi；10 grams of Caulis Spatholobi；30 grams of Radix Angelicae Sinensis；10 grams of tuber fleeceflower stem；30 grams of olibanum；
10 grams of myrrh；30 grams of rhizoma zingiberis；6 grams of muscone.
Preparation method: spare at medicinal powder by the above raw material mixed grinding to 300 mesh.
Application method: cleaning SHENQUE acupoint is included in 2 grams above-mentioned of navel moxibustion medicinal powder, 50 grams of ginger powder are tuned into pie with warm water, put
On Shenque, medicinal powder is covered.It puts 7 grams of 20:1 moxa above to light, moxibustion three is strong or one is strong, once a day.Pay attention to keeping warm, is within 5 days
One course for the treatment of.
Embodiment 4
Raw material (gram) is weighed according to following weight:
15 grams of fennel seeds；25 grams of cortex cinnamomi；15 grams of ramulus cinnamomi；25 grams of Caulis Spatholobi；15 grams of Radix Angelicae Sinensis；25 grams of tuber fleeceflower stem；15 grams of olibanum；
25 grams of myrrh；15 grams of rhizoma zingiberis；3 grams of muscone.
Preparation method: spare at medicinal powder by the above raw material mixed grinding to 300 mesh.
Application method: cleaning SHENQUE acupoint is included in 2 grams above-mentioned of navel moxibustion medicinal powder, 50 grams of ginger powder are tuned into pie with warm water, put
On Shenque, medicinal powder is covered.7 grams of 20:1 moxa are put above to light, and strengthen for moxibustion three or one is strong, once a day.Pay attention to keeping warm, 5 days
It is as a treatment course.
Embodiment 5
Raw material (gram) is weighed according to following weight:
25 grams of fennel seeds；15 grams of cortex cinnamomi；25 grams of ramulus cinnamomi；15 grams of Caulis Spatholobi；25 grams of Radix Angelicae Sinensis；15 grams of tuber fleeceflower stem；25 grams of olibanum；
15 grams of myrrh；25 grams of rhizoma zingiberis；5 grams of muscone.
Preparation method: same as Example 1.
Application method: same as Example 1.
The typical clinical trial example of the present invention:
Mr. Wang, female, 30 years old, cold exacerbation was met in more than 10 years of dysmenorrhea, lower abdomen shouting pain when in the period every time, and menstruation has clot, face
Color mulberry.Dark tongue quality has ecchymosis, deep thready pulse.2 grams of medicinal powder for giving the preparation of embodiment 1 are placed on inside navel, and according to implementation
The application method that example 1 provides is placed on above medicinal powder after reconciling 50 grams of ginger powder with warm water, then is put 7 grams of moxas and lighted strong a, company
Continuous three is strong, and once a day, 5 days courses for the treatment of, patient's pain disappears after three courses for the treatment of, does not there is recurrence.
Tan, female 45 years old, abdominal distension 2 years, aggravate, pale tongue with thin fur is white, deep thready pulse afterwards to the cold.B ultrasound display hepatic cyst 3.0 ×
2.7mm, patient are reluctant to perform the operation, and seek knowledge in external treatment with Chinese medicine therapy；Navel moxibustion therapy is given, the medicinal powder 2 of the preparation of embodiment 2 is given
It gram is placed on inside navel, and the application method provided according to embodiment 2, navel moxibustion temperature is placed on inside navel through 2 grams of powder, by ginger powder
50 grams reconciled with warm water after be placed on above medicinal powder, then put 7 grams of moxas light it is one strong, continuous 3 it is strong once a day, cooperate the outstanding moxibustion in part
Therapy does the disappearance of ultrasound diagnosis tumour once a day after five courses for the treatment of, 8 courses for the treatment of.
Leaf, male 56 years old, impotence is not lifted 7 years, and invalid by multi-treatment, face lividity, pale tongue with thin fur is white, trick ice
It is cool, dampness of scrotum, deep,thready and forceless pulse.2 grams of medicinal powder for giving the preparation of embodiment 3 are placed on inside navel, and are provided according to embodiment 3
Application method, be placed on above medicinal powder after 50 grams of ginger powder are reconciled with warm water, then put 7 grams of moxas and light one strong, continuous three is strong,
Once a day, 5 days courses for the treatment of.Patient has obvious morning vigorous after 3 courses for the treatment of, and confidence increases, and giving after 3 courses for the treatment of of continual cure can be into
Row normal sexuality.Observation does not have recurrence in 1 year.
Journey, female, 36 years old, panesthesia was faint, and loss of appetite, sleep quality is not good enough, and season is easy to have a running nose, sense
It emits.2 grams of medicinal powder for giving the preparation of embodiment 4 are placed on inside navel, and the application method provided according to embodiment 4, by ginger powder
50 grams reconciled with warm water after be placed on above medicinal powder, then put 7 grams of moxas and light one strong, continuous three is strong, once a day, 5 days courses for the treatment of,
After 6 courses for the treatment of, patient sleeps are high-quality, and body is significantly reduced without weak sense, times of common cold.Observation 1 is only flu 1 time.
It should be noted that unless otherwise indicated, technical term or scientific term used in this application should be this Shen
It please the ordinary meaning that is understood of one of ordinary skill in the art.
The preferable specific embodiment of the above, only the application, but the protection scope of the application is not limited thereto,
Within the technical scope of the present application, any changes or substitutions that can be easily thought of by anyone skilled in the art,
Should all it cover within the scope of protection of this application.Therefore, the protection scope of the application should be with scope of protection of the claims
Subject to.
Claims (3)
1. a kind of pharmaceutical composition for Shenque Moxa, the bulk pharmaceutical chemicals including following parts by weight:
10-30 parts of fennel seeds；10-30 parts of cortex cinnamomi；10-30 parts of ramulus cinnamomi；10-30 parts of Caulis Spatholobi；10-30 parts of Radix Angelicae Sinensis；Tuber fleeceflower stem 10-
30 parts；10-30 parts of olibanum of part；10-30 parts of myrrh；10-30 parts of rhizoma zingiberis；2-6 parts of muscone.
2. the pharmaceutical composition according to claim 1 for Shenque Moxa, the bulk pharmaceutical chemicals including following parts by weight:
15-25 parts of fennel seeds；15-25 parts of cortex cinnamomi；15-25 parts of ramulus cinnamomi；15-25 parts of Caulis Spatholobi；15-25 parts of Radix Angelicae Sinensis；Tuber fleeceflower stem 15-
25 parts；15-25 parts of olibanum of part；15-25 parts of myrrh；15-25 parts of rhizoma zingiberis；3-5 parts of muscone.
3. the pharmaceutical composition according to claim 1 or 2 for Shenque Moxa, the bulk pharmaceutical chemicals including following parts by weight:
20 parts of fennel seeds；20 parts of cortex cinnamomi；20 parts of ramulus cinnamomi；20 parts of Caulis Spatholobi；20 parts of Radix Angelicae Sinensis；20 parts of tuber fleeceflower stem；20 parts of olibanum；Myrrh
20 parts；20 parts of rhizoma zingiberis；4 parts of muscone.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910578046.4A CN110404038A (en) | 2019-06-28 | 2019-06-28 | Pharmaceutical composition for Shenque Moxa |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910578046.4A CN110404038A (en) | 2019-06-28 | 2019-06-28 | Pharmaceutical composition for Shenque Moxa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110404038A true CN110404038A (en) | 2019-11-05 |
Family
ID=68358568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910578046.4A Pending CN110404038A (en) | 2019-06-28 | 2019-06-28 | Pharmaceutical composition for Shenque Moxa |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110404038A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1037085A (en) * | 1989-05-03 | 1989-11-15 | 第二重型机器厂职工医院 | The preparation method of dysmenorrhea meprobamate |
| CN102198260A (en) * | 2011-05-27 | 2011-09-28 | 山东中医药大学 | Medicine-partitioned navel moxibustion Chinese medicinal composition for treating dysmenorrhea |
| CN103861076A (en) * | 2014-04-01 | 2014-06-18 | 彭昌 | Traditional Chinese medicine warm-moxibustion bag and application thereof |
-
2019
- 2019-06-28 CN CN201910578046.4A patent/CN110404038A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1037085A (en) * | 1989-05-03 | 1989-11-15 | 第二重型机器厂职工医院 | The preparation method of dysmenorrhea meprobamate |
| CN102198260A (en) * | 2011-05-27 | 2011-09-28 | 山东中医药大学 | Medicine-partitioned navel moxibustion Chinese medicinal composition for treating dysmenorrhea |
| CN103861076A (en) * | 2014-04-01 | 2014-06-18 | 彭昌 | Traditional Chinese medicine warm-moxibustion bag and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 朱英等: "隔药灸治疗原发性痛经临床观察 ", 《针灸临床杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102357133A (en) | Chinese medicinal tea-substitution brewing potion for treating allergic rhinitis | |
| CN100574783C (en) | A kind of antiinflammation pain-stopping pharmaceutical | |
| CN104857092A (en) | Traditional Chinese medicine suppository for treating constipation | |
| CN100584354C (en) | A medicine for treating zoster sequela neuralgia | |
| CN102293853B (en) | Chinese medicinal pills for treating Bi syndrome | |
| CN102430068A (en) | Vinegar and traditional Chinese medicine combined fomentation vinegar with functions of removing stasis, invigorating kidneys and treating arthralgia and preparation method thereof | |
| CN103610774B (en) | Treat the external medicine composition of soft wound | |
| CN110404038A (en) | Pharmaceutical composition for Shenque Moxa | |
| CN104857091A (en) | Traditional Chinese medicine composition for treating renal calculus | |
| CN103877462A (en) | External liniment for treating psoriasis and preparation method thereof | |
| CN100579572C (en) | Orally-administered Chinese medicinal composition for treating migraine pain | |
| CN103933481B (en) | External used medicine of a kind for the treatment of of cancer pain and preparation method thereof | |
| CN104398949B (en) | One kind treats prostatitic traditional Chinese medicine oral liquid | |
| CN102274337B (en) | Chinese medicinal medicament for treating angioneurotic headache | |
| CN103393871A (en) | Externally used medicinal liquor for treating rheumatism, arthralgia and traumatic injury | |
| CN103599407B (en) | A kind ofly be used for the treatment of prostatitis and with the Chinese medicine composition of insomnia and dreamful sleep | |
| CN102688456B (en) | Chinese medicinal composition for treating chronic prostatitis | |
| CN106237051A (en) | A kind of medicine treating cyclomastopathy, mammary gland tumor and preparation method thereof | |
| Lü et al. | Observation on the effect of acupoint injection plus massage therapy on primary dysmenorrhea | |
| CN101112497A (en) | Medicine for treating prostatitis and method for preparing the same | |
| CN101195002A (en) | Chinese medicine emplastrum for releasing ache and health care | |
| CN105311489A (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN116763882A (en) | Sanjiu plaster and preparation method and application thereof | |
| CN104352846A (en) | Traditional Chinese medicinal composition for treating senile constipation | |
| CN104958517A (en) | Traditional Chinese medicine composition for treating Qi-stagnation and blood stasis type prostatitis and preparing method of traditional Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191105 |
|
| RJ01 | Rejection of invention patent application after publication |